To include your compound in the COVID-19 Resource Center, submit it here.

AnaptysBio raises $205.5M in follow-on

AnaptysBio Inc. (NASDAQ:ANAB) raised $205.5 million through the sale of 3 million

Read the full 121 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE